In a study including 96 biopsy-proven adult CeD patients, I-FABP levels were higher in untreated CeD compared with controls (median 691 pg mL−1 vs. 178 pg mL−1, p < 0.001) and the level declined with GFD [76]. The gene discussed is FABP2; the disease is cranioectodermal dysplasia.